ISOPROTERENOL IMPAIRS THE RAT CORONARY VASCULATURE - EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION

被引:3
|
作者
ROUX, S
CLOZEL, JP
FISCHLI, W
KUHN, H
机构
关键词
ISOPROTERENOL; ACE INHIBITION; CILAZAPRIL; VASCULAR REMODELING; CORONARY RESERVE; CORONARY BLOOD FLOW; MYOCARDIAL NECROSIS;
D O I
10.1097/00005344-199204000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of the present study was to evaluate whether in addition to its myocardial effects, chronic beta-adrenergic stimulation with isoproterenol could modify the coronary vasculature. For this purpose, rats were treated for 2 weeks with isoproterenol, and the hearts were isolated for determination of the minimal coronary vascular resistance under maximal vasodilation and then perfused-fixed for morphometry of the coronary arteries. In addition, because isoproterenol stimulates the reninangiotensin system (RAS), the effects of angiotensin-converting enzyme (ACE) inhibition on the coronary vasculature were assessed. Isoproterenol increased heart weight by 65% and minimal coronary resistance by 55%. This effect was associated with medial thickening in intermediate (32%) and large coronary arterioles (26%). Cilazapril, a long-acting ACE inhibitor, completely prevented the medial thickening induced by isoproterenol and normalized the minimal coronary resistance. We conclude that impairment of the rat coronary vasculature induced by chronic beta-adrenergic stimulation might be in part mediated by activation of the RAS.
引用
收藏
页码:525 / 531
页数:7
相关论文
共 50 条
  • [11] Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects
    Burnier, M
    Brunner, HR
    EXPERIMENTAL NEPHROLOGY, 1996, 4 : 41 - 46
  • [12] ANGIOTENSIN CONVERTING ENZYME-INHIBITION DOES NOT PREVENT THE NATRIURETIC EFFECT OF FELODIPINE
    VANHAMERSVELT, HW
    WETZELS, JFM
    KLOKE, HJ
    KOENE, RAP
    HUYSMANS, FTM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (03) : 471 - 477
  • [13] ANGIOTENSIN-I CONVERTING ENZYME-INHIBITION - CLINICAL EFFECTS IN CHRONIC RENAL-DISEASE
    DEJONG, PE
    HEEG, JE
    APPERLOO, AJ
    DEZEEUW, D
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (05) : 85 - 88
  • [14] Angiotensin-Converting Enzyme Inhibitors
    Izzo, Joseph L., Jr.
    Weir, Matthew R.
    JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (09) : 667 - 675
  • [15] PGE(2) production after angiotensin-converting enzyme inhibition
    Johnsen, SA
    Persson, IB
    Aurell, M
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1997, 31 (01): : 81 - 88
  • [16] In vitro and in silico inhibition of angiotensin-converting enzyme by carbohydrates and cyclitols
    Endringer, Denise C.
    Oliveira, Osmair V.
    Braga, Fernao C.
    CHEMICAL PAPERS, 2014, 68 (01) : 37 - 45
  • [17] Angiotensin-converting enzyme inhibition in cirrhotic patients - Pharmacokinetics of ramipril
    Pidlich, J
    Cichini, GM
    Reinisch, W
    PeckRadosavljevic, M
    Renner, F
    ACTA MEDICA AUSTRIACA, 1997, 24 (01) : 15 - 18
  • [18] In vitro and in silico inhibition of angiotensin-converting enzyme by carbohydrates and cyclitols
    Denise C. Endringer
    Osmair V. Oliveira
    Fernão C. Braga
    Chemical Papers, 2014, 68 : 37 - 45
  • [19] Angiotensin-converting enzyme inhibition after experimental myocardial infarct
    Duka, Arvi
    Kintsurashvili, Ekaterina
    Duka, Irena
    Ona, Deborah
    Hopkins, Teresa A.
    Bader, Michael
    Gavras, Irene
    Gavras, Haralambos
    HYPERTENSION, 2008, 51 (05) : 1352 - 1357
  • [20] INSULIN SENSITIVITY IN NORMOTENSIVE SUBJECTS DURING ANGIOTENSIN CONVERTING ENZYME-INHIBITION WITH FOSINOPRIL
    ALLEMANN, Y
    BAUMANN, S
    JOST, M
    FERRARI, P
    SHAW, S
    RIESEN, W
    WEIDMANN, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (03) : 275 - 280